Miroslava Kissova

Via Abbiategrasso 207
Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Proteomic Analysis Uncovers Enhanced Inflammatory Phenotype and Distinct Metabolic Changes in IDH1 Mutant Glioma Cells.

Proteomic Analysis Uncovers Enhanced Inflammatory Phenotype and Distinct Metabolic Changes in IDH1 Mutant Glioma Cells.

Journal: International journal of molecular sciences

Published: June 25, 2025

RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells.

RNaseH2 inhibition potentiates temozolomide response in patient derived glioblastoma cells.

Journal: Scientific reports

Published: April 08, 2025

JAK inhibitors remove innate immune barriers facilitating viral propagation.

JAK inhibitors remove innate immune barriers facilitating viral propagation.

Journal: NAR molecular medicine

Published: March 14, 2025

A loss-of-function mutation in human Oxidation Resistance 1 disrupts the spatial-temporal regulation of histone arginine methylation in neurodevelopment.

A loss-of-function mutation in human Oxidation Resistance 1 disrupts the spatial-temporal regulation of histone arginine methylation in neurodevelopment.

Journal: Genome biology

Published: May 21, 2022

A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.

A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.

Journal: International journal of molecular sciences

Published: January 20, 2021

Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.

Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach †.

Journal: Journal of medicinal chemistry

Published: November 16, 2019

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.

Journal: European journal of medicinal chemistry

Published: May 08, 2019

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment.

Journal: Bioorganic & medicinal chemistry letters

Published: July 19, 2018

Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases.

Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases.

Journal: Journal of medicinal chemistry

Published: January 26, 2017

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.

Journal: European journal of medicinal chemistry

Published: September 20, 2016

Ribonucleotide incorporation by human DNA polymerase η impacts translesion synthesis and RNase H2 activity.

Ribonucleotide incorporation by human DNA polymerase η impacts translesion synthesis and RNase H2 activity.

Journal: Nucleic acids research

Published: September 15, 2016

The human tyrosine kinase Kit and its gatekeeper mutant T670I, show different kinetic properties: Implications for drug design.

The human tyrosine kinase Kit and its gatekeeper mutant T670I, show different kinetic properties: Implications for drug design.

Journal: Bioorganic & medicinal chemistry

Published: June 07, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026